Ilhan, O. Et Al. 2019. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl , 19524.

Ilhan, O., Cengiz Seval, G., Toprak, S. K., Civriz Bozdag, S., Yuksel, M. K., Topcuoglu, P., ... Arslan, O.(2019). Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, 19524.

Ilhan, Osman Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?," JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, 19524, 2019

Ilhan, Osman Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, pp.19524, 2019

Ilhan, O. Et Al. (2019) . "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15_suppl, p.19524.

@article{article, author={Osman Ilhan Et Al. }, title={Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={19524} }